NCT02552238: A trial that was reported late by Bracco Diagnostics, Inc
This trial has reported, although it was 760 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02552238 |
|---|---|
| Title | A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 12, 2015 |
| Completion date | June 22, 2017 |
| Required reporting date | June 22, 2018, midnight |
| Actual reporting date | July 21, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 760 |